| |
|
|
|
Proteostasis Ther
|
|
2.00 -0.04 (-1.96%) |
8/18/2017 4:00pm |
|
Open: |
2.06 |
Pre close: |
2.04 |
Target:
|
4.46 
|
|
High: |
2.10 |
Low: |
1.94 |
Resistance:
|
3.82
4.99
|
|
Volume: |
169,024 |
Market Cap: |
50.20M |
Support:
|
1.94
1.61
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.12
|
MACD |
MACD(12,26):
|
-0.50  |
|
MA(20): |
2.49 |
Signal(12,26,9): |
-0.53 |
|
MA(100): |
4.63 |
Stochastic Oscillator |
%K(14,3):
|
5.04 |
|
MA(250): |
9.54 |
%D(3): |
8.02 |
|
Average Volume(K) |
3-Month: |
17508
|
52-Week |
High:
|
18.48 |
|
10-Days: |
3735 |
Low: |
1.94 |
|
RSI |
RSI(14):
|
23.26 |
Change(%): |
-89.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.990 |
Return on Equity (ttm) |
-127.8 |
Shares Out. (M) |
25.10 |
|
EPS Est. Current Year |
-2.520 |
Return on Assets (ttm) |
-61.7 |
Shares Float (M) |
12.63 |
|
EPS Est. Next Year |
-2.600 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.660 |
Qtrly Rev. Growth |
-21.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-2.562 |
Gross Profit (p.s.) |
0.334 |
Shares Short (K) |
43 |
|
Book Value (p.s.) |
2.680 |
EBITDA (p.s.) |
-2.090 |
P/E |
-1.01 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.75 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-54.41 |
P/S |
152121216.00 |
|
Operating Margin |
-664.11 |
Levered Free Cash Flow
(M) |
-32.84 |
P/CF |
-0.92 |
|
|
|
|
 |
|
|
|
